Richard F. Pops
Director, Neurocrine Biosciences.
Companies
- AlkermesBoard member Sep 20, 2011 to now1
- Neurocrine BiosciencesBoard member Jun 30, 2006 to now2
- AlkermesChief executive officer Sep 20, 2011 to Aug 7, 20261
- Epizyme, Inc.Board member May 30, 2013 to Jun 2, 20203
- Acceleron PharmaBoard member Sep 18, 2013 to Jan 29, 20194
- AlkermesPresident Nov 20, 2009 to Sep 20, 20115
- AlkermesBoard member May 4, 2006 to Sep 20, 20116
- AlkermesChief executive officer May 4, 2006 to Sep 20, 20116
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Neurocrine Biosciences NBIX37,798 shares7$5.2M at $137.36May 21, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 21, 2026Exercised options 3,318 shares of Neurocrine Biosciences7
- May 15, 2026Sold 15,000 shares at $157.65 of Neurocrine Biosciences8
- May 15, 2026Exercised options 15,000 shares at $47.89 of Neurocrine Biosciences8
- Feb 5, 2026Shares withheld for tax 62,230 shares at $33.55 of CIK 15202629
- Feb 5, 2026Granted 149,580 shares of CIK 15202629
- May 22, 2025Exercised options 2,869 shares of Neurocrine Biosciences10
- Feb 6, 2025Shares withheld for tax 79,925 shares at $31.39 of CIK 152026211
- Feb 6, 2025Granted 190,640 shares of CIK 152026211
- May 17, 2024Sold 2,100 shares at $141.84 of Neurocrine Biosciences12
- May 17, 2024Exercised options 4,199 shares of Neurocrine Biosciences12
- Mar 13, 2024Sold 23,200 shares at $140.33 of Neurocrine Biosciences13
- Mar 13, 2024Exercised options 23,200 shares at $42.76 of Neurocrine Biosciences13
- Mar 11, 2024Sold 100 shares at $140.00 of Neurocrine Biosciences14
- Mar 11, 2024Exercised options 100 shares at $42.76 of Neurocrine Biosciences14
- Mar 8, 2024Sold 1,700 shares at $140.05 of Neurocrine Biosciences14
- Mar 8, 2024Exercised options 1,700 shares at $42.76 of Neurocrine Biosciences14
- Feb 20, 2024Sold 15,000 shares at $132.47 of Neurocrine Biosciences15
- Feb 20, 2024Exercised options 15,000 shares at $12.98 of Neurocrine Biosciences15
- Feb 8, 2024Shares withheld for tax 91,757 shares at $26.77 of CIK 152026216
- Feb 8, 2024Granted 218,551 shares of CIK 152026216
- Feb 21, 2023Shares withheld for tax 14,386 shares at $27.77 of CIK 152026217
- Feb 21, 2023Exercised options 32,400 shares of CIK 152026217
- Feb 20, 2023Shares withheld for tax 53,145 shares at $28.07 of CIK 152026217
- Feb 20, 2023Granted 119,713 shares of CIK 152026217
- Jan 3, 2023Sold 15,000 shares at $119.20 of Neurocrine Biosciences18
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAlkermes, Board member
- 2SEC EDGARNeurocrine Biosciences, Board member
- 3SEC EDGAREpizyme, Inc., Board member
- 4SEC EDGARAcceleron Pharma, Board member
- 5SEC EDGARAlkermes, President
- 6SEC EDGARAlkermes, Board member
- 7
- 8SEC EDGARForm 4 filed May 18, 2026
- 9SEC EDGARForm 4 filed Feb 6, 2026
- 10SEC EDGARForm 4 filed May 22, 2025
- 11SEC EDGARForm 4 filed Feb 7, 2025
- 12SEC EDGARForm 4 filed May 21, 2024
- 13SEC EDGARForm 4 filed Mar 15, 2024
- 14SEC EDGARForm 4 filed Mar 12, 2024
- 15SEC EDGARForm 4 filed Feb 22, 2024
- 16SEC EDGARForm 4 filed Feb 12, 2024
- 17SEC EDGARForm 4 filed Feb 22, 2023
- 18SEC EDGARForm 4 filed Jan 5, 2023